• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

426
71
48
47
24

COUNTRY

46
17
5
5
5

PRICE

292
545
1,170
1,448

PUBLISHED

7
116
482
1,448

PRODUCT TYPE

1,350
67
18
13

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Fibromyalgia - Pipeline Review, H1 2015

Fibromyalgia - Pipeline Review, H1 2015 Summary This, ‘Fibromyalgia - Pipeline Review, H1 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

The Older Adult Psychotherapy Treatment Planner, with DSM-5 Updates, 2nd Edition.

This timesaving resource features: - Treatment plan components for 30 behaviorally based presenting problems - Over 1,000 prewritten treatment goals, objectives, and interventions—plus space...

January 2015

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015 Summary This, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015’, provides...

January 2015
FROM

Obsessive-Compulsive Disorder - Pipeline Review, H1 2015

Obsessive-Compulsive Disorder - Pipeline Review, H1 2015 Summary This, ‘Obsessive-Compulsive Disorder - Pipeline Review, H1 2015’, provides an overview of the Obsessive-Compulsive Disorder’s therapeutic...

January 2015
FROM

Sedation - Pipeline Review, H1 2015

Sedation - Pipeline Review, H1 2015 Summary This, ‘Sedation - Pipeline Review, H1 2015’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

January 2015
FROM

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015

Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015 Summary This, ‘Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2015’, provides an overview of the Post-Traumatic Stress...

January 2015
FROM

Fatigue - Pipeline Review, H1 2015

Fatigue - Pipeline Review, H1 2015 Summary This, ‘Fatigue - Pipeline Review, H1 2015’, provides an overview of the Fatigue’s therapeutic pipeline. This report provides comprehensive information on...

January 2015
FROM

Brain Injury - Pipeline Review, H1 2015

Brain Injury - Pipeline Review, H1 2015 Summary This, ‘Brain Injury - Pipeline Review, H1 2015’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015 Summary This, ‘Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H1 2015’, provides an overview of the Secondary...

January 2015
FROM

Nerve Injury - Pipeline Review, H1 2015

Nerve Injury - Pipeline Review, H1 2015 Summary This, ‘Nerve Injury - Pipeline Review, H1 2015’, provides an overview of the Nerve Injury’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Dementia - Pipeline Review, H1 2015

Dementia - Pipeline Review, H1 2015 Summary This, ‘Dementia - Pipeline Review, H1 2015’, provides an overview of the Dementia’s therapeutic pipeline. This report provides comprehensive information...

January 2015
FROM

Status Epilepticus - Pipeline Review, H1 2015

Status Epilepticus - Pipeline Review, H1 2015 Summary This, ‘Status Epilepticus - Pipeline Review, H1 2015’, provides an overview of the Status Epilepticus’s therapeutic pipeline. This report provides...

January 2015
FROM

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015 Summary This, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic...

January 2015
FROM

Autism - Pipeline Review, H1 2015

Autism - Pipeline Review, H1 2015 Summary This, ‘Autism - Pipeline Review, H1 2015’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

January 2015
FROM

Tardive Dyskinesia - Pipeline Review, H1 2015

Tardive Dyskinesia - Pipeline Review, H1 2015 Summary This, ‘Tardive Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. This report provides...

January 2015
FROM

Diabetic Neuropathic Pain - Pipeline Review, H1 2015

Diabetic Neuropathic Pain - Pipeline Review, H1 2015 Summary This, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline. This...

January 2015
FROM

Post-Operative Pain - Pipeline Review, H1 2015

Post-Operative Pain - Pipeline Review, H1 2015 Summary This, ‘Post-Operative Pain - Pipeline Review, H1 2015’, provides an overview of the Post-Operative Pain’s therapeutic pipeline. This report...

January 2015
FROM

Global Anxiety Disorders Market 2015-2019

About Anxiety Disorders Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response....

January 2015
FROM

Eastern Equine Encephalitis - Pipeline Review, H2 2014

Eastern Equine Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Eastern Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Eastern Equine Encephalitis’s therapeutic...

December 2014
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.